+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Point-of-care Molecular Diagnostics Market Analysis & Forecast to 2023-2033: Market By Technology; By Test Location; By Application; By End-user; and by Region

  • PDF Icon

    Report

  • 145 Pages
  • July 2023
  • Region: Global
  • Erevna Healthcare
  • ID: 5848819
The global point-of-care molecular diagnostics market size was estimated to be USD 7.45 billion in 2023 and is expected to reach at USD 20.7 billion by 2033 with a CAGR of 9.75% during the forecast period 2023-2033. The point-of-care molecular diagnostics market is anticipated to grow over the next few years as a result of rising demand for rapid tests and a significant number of new point-of-care test product introductions. In addition, one of the most important drivers of market expansion is ongoing improvement in the quality of the products available on the shelves.

Rising incidence of cardiovascular diseases, diabetes, cancer, and infectious disorders is expected to fuel the market growth during the forecast period. By 2030, cardiovascular diseases are expected to be responsible for 23.3 million deaths, according to the WHO. The increasing prevalence of cardiovascular diseases worldwide is caused by factors including the global increase in smoking, bad diets, and rising obesity rates. The need for POC MDx tests has increased as a result of the existence of unmet medical needs relating to cardiovascular diseases and the development in patient awareness of various advancements in disease diagnostics.

By Technology, PCR-based was the highest revenue-grossing segment in the global point-of-care molecular diagnostics market in 2022 owing to rising adoption of diagnostic tests of infectious diseases, increasing technological advancements, growing advanced product launches, and surge in mergers & acquisitions within key market players. For instance, in September 2021, F. Hoffmann-La Roche Ltd. has purchased TIB Molbiol in order to enhance its collection of PCR tests, incorporating a diverse set of assays for detecting infectious diseases. Additionally, Genetic sequencing-based is predicted to grow at fastest CAGR during the forecast period owing to the rising demand for personalized genome mapping and growing research & development activities.

By Test Location, OTC was the highest revenue-grossing segment in the global point-of-care molecular diagnostics market in 2022 owing to surge in outbreak of infectious diseases and growing demand from forensic sciences, and increasing launch of diagnostic products. Additionally, POC is predicted to grow at fastest CAGR during the forecast period owing to the rising demand for molecular diagnostics, surge in development molecular diagnostic platforms, and increasing introduction of advanced products. For instance, In July 2021, QuantuMDx has unveiled its rapid point-of-care PCR system, known as Q-POC, for the diagnosis of Covid-19.

By Application, Infectious Diseases was the highest revenue-grossing segment in the global point-of-care molecular diagnostics market in 2022 owing to increasing demand for molecular tests, rising new product launches, growing adoption of advanced molecular diagnostic techniques. Additionally, Oncology is predicted to grow at fastest CAGR during the forecast period owing to the increasing prevalence of cancer and growing product launches. For instance, in May 2022, Inex Innovate has received CE approval for their OvaCis Rapid Test, a point-of-care diagnostic tool designed to differentiate between benign and malignant ovarian cysts. The test offers results within 15 minutes, significantly reducing the testing duration.

By End-user, Decentralized Labs was the highest revenue-grossing segment in the global point-of-care molecular diagnostics market in 2022 owing to increase in accurate molecular analysis, rising advances in personalized medicine, and growing usage of point-of-care technology, and surge in investment by kay market players for the development of point-of-care molecular diagnostic platforms. For instance, in December 2021, FIND has allocated a total of USD 21 million in investments to Biomeme, Bioneer, Qlife, and SD Biosensor. This funding aims to expedite the progress, production, and introduction of cost-effective molecular diagnostic platforms for point-of-care use, capable of detecting various pathogens. Additionally, Home-care is predicted to grow at fastest CAGR during the forecast period owing to the increasing lifestyle related diseases like obesity, diabetes, high blood pressure, growing adoption of home health care facilities, and rising launch of new products.

North America region is anticipated for the highest revenue share during the forecast period owing to the increasing prevalence of infectious diseases & cancer, rising healthcare infrastructure, surge in adoption of technologically advanced infectious disease testing, growing government funding & support, and increasing introduction of advanced diagnostic testing products. For instance, In March 2020, Abbott Laboratories has introduced a novel point-of-care solution for the detection of COVID-19. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the surge in approvals for molecular diagnostic kits, growing demand for rapid & efficient testing. For instance, In April 2023, QIAGEN has recently introduced QIAstat-Dx in Japan, featuring a respiratory panel specifically designed for syndromic testing.

Segmentation: Point-of-care Molecular Diagnostics Market Report 2022-2033

Point-of-care Molecular Diagnostics Market Analysis & Forecast By Technology 2022-2033 (Revenue USD Bn)

  • Genetic Sequencing-based
  • PCR-based
  • Microarray-based
  • Hybridization-based

Point-of-care Molecular Diagnostics Market Analysis & Forecast By Test Location 2022-2033 (Revenue USD Bn)

  • POC
  • OTC

Point-of-care Molecular Diagnostics Market Analysis & Forecast By Application 2022-2033 (Revenue USD Bn)

  • Oncology
  • Prenatal Testing
  • Hematology

Infectious Diseases

  • Clostridium difficile POC
  • Pneumonia or Streptococcus associated infections
  • HIV POC
  • HCV POC
  • TB and drug-resistant TB POC
  • Influenza/Flu POC
  • MRSA POC
  • Respiratory syncytial virus (RSV) POC
  • Endocrinology

Point-of-care Molecular Diagnostics Market Analysis & Forecast By End-user 2022-2033 (Revenue USD Bn)

  • Hospitals
  • Decentralized Labs
  • Assisted Living Healthcare Facilities
  • Home-care

Point-of-care Molecular Diagnostics Market Analysis & Forecast by Region 2022-2033 (Revenue USD Bn)

North America

  • U.S
  • Canada

Europe

  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM

Middle East & Africa

  • South Africa
  • GCC
  • Rest of MEA

Table of Contents

1. Research Methodology
1.1. Study Objectives
1.2. Study Scope
1.3. Research Assumptions
1.4. Research Framework
2. Introduction
2.1. Market Definition
2.2. Global Point-of-care Molecular Diagnostics Market Overview
3. Executive Summary
4. Market Environment Analysis
4.1. Porter’s 5 Forces Analysis
4.2. PESTEL Analysis
4.3. SWOT Analysis
5. Market Dynamics
5.1. Drivers Analysis
5.2. Restraints Analysis
5.3. Opportunities Analysis
5.4. Threats Analysis
5.5. Trend Analysis
6. COVID-19 Impact Analysis
7. Point-of-care Molecular Diagnostics Market: Technology Estimates & Trend Analysis
7.1. Technology Segment Opportunity Analysis
7.2. Genetic Sequencing-based
7.2.1. Genetic Sequencing-based Market Analysis & Forecast, 2022-2033 (Revenue, USD Bn)
7.3. PCR-based
7.3.1. PCR-based Market Analysis & Forecast, 2022-2033 (Revenue, USD Bn)
7.4. Microarray-based
7.4.1. Microarray-based Market Analysis & Forecast, 2022-2033 (Revenue, USD Bn)
7.5. Hybridization-based
7.5.1. Hybridization-based Market Analysis & Forecast, 2022-2033 (Revenue, USD Bn)
8. Point-of-care Molecular Diagnostics Market: Test Location Estimates & Trend Analysis
8.1. Test Location Segment Opportunity Analysis
8.2. POC
8.2.1. POC Market Analysis & Forecast, 2022-2033 (Revenue, USD Bn)
8.3. OTC
8.3.1. OTC Market Analysis & Forecast, 2022-2033 (Revenue, USD Bn)
9. Point-of-care Molecular Diagnostics Market: Application Estimates & Trend Analysis
9.1. Application Segment Opportunity Analysis
9.2. Oncology
9.2.1. Oncology Market Analysis & Forecast, 2022-2033 (Revenue, USD Bn)
9.3. Prenatal Testing
9.3.1. Prenatal Testing Market Analysis & Forecast, 2022-2033 (Revenue, USD Bn)
9.4. Hematology
9.4.1. Hematology Market Analysis & Forecast, 2022-2033 (Revenue, USD Bn)
9.5. Infectious Diseases
9.5.1. Infectious Diseases Market Analysis & Forecast, 2022-2033 (Revenue, USD Bn)
9.5.1.1. Clostridium difficile POC
9.5.1.1.1. Clostridium difficile POC Market Analysis & Forecast, 2022-2033 (Revenue, USD Bn)
9.5.1.2. Pneumonia or Streptococcus associated infections
9.5.1.2.1. Pneumonia or Streptococcus associated infections Market Analysis & Forecast, 2022-2033 (Revenue, USD Bn)
9.5.1.3. HIV POC
9.5.1.3.1. HIV POC Market Analysis & Forecast, 2022-2033 (Revenue, USD Bn)
9.5.1.4. HCV POC
9.5.1.4.1. HCV POC Market Analysis & Forecast, 2022-2033 (Revenue, USD Bn)
9.5.1.5. TB and drug-resistant TB POC
9.5.1.5.1. TB and drug-resistant TB POC Market Analysis & Forecast, 2022-2033 (Revenue, USD Bn)
9.5.1.6. Influenza/Flu POC
9.5.1.6.1. Influenza/Flu POC Market Analysis & Forecast, 2022-2033 (Revenue, USD Bn)
9.5.1.7. MRSA POC
9.5.1.7.1. MRSA POC Market Analysis & Forecast, 2022-2033 (Revenue, USD Bn)
9.5.1.8. Respiratory syncytial virus (RSV) POC
9.5.1.8.1. Respiratory syncytial virus (RSV) POC Market Analysis & Forecast, 2022-2033 (Revenue, USD Bn)
9.6. Endocrinology
9.6.1. Endocrinology Market Analysis & Forecast, 2022-2033 (Revenue, USD Bn)
10. Point-of-care Molecular Diagnostics Market: End-user Estimates & Trend Analysis
10.1. End-user Segment Opportunity Analysis
10.2. Hospitals
10.2.1. Hospitals Market Analysis & Forecast, 2022-2033 (Revenue, USD Bn)
10.3. Decentralized Labs
10.3.1. Decentralized Labs Market Analysis & Forecast, 2022-2033 (Revenue, USD Bn)
10.4. Assisted Living Healthcare Facilities
10.4.1. Assisted Living Healthcare Facilities Market Analysis & Forecast, 2022-2033 (Revenue, USD Bn)
10.5. Home-care
10.5.1. Home-care Market Analysis & Forecast, 2022-2033 (Revenue, USD Bn)
11. Regional Market Analysis
11.1. Regional Market Opportunity Analysis
12. North America Point-of-care Molecular Diagnostics Market
12.1. North America Point-of-care Molecular Diagnostics Market
12.1.1. North America Point-of-care Molecular Diagnostics Market Size and Forecast, 2022-2033 (Revenue USD Bn)
12.1.2. North America Point-of-care Molecular Diagnostics Market Size and Forecast, By Country, 2022-2033 (Revenue USD Bn)
12.1.3. North America Point-of-care Molecular Diagnostics Market Size and Forecast, By Technology, 2022-2033 (Revenue USD Bn)
12.1.4. North America Point-of-care Molecular Diagnostics Market Size and Forecast, By Application, 2022-2033 (Revenue USD Bn)
12.1.5. North America Point-of-care Molecular Diagnostics Market Size and Forecast, By Test Location, 2022-2033 (Revenue USD Bn)
12.1.6. North America Point-of-care Molecular Diagnostics Market Size and Forecast, By End-user, 2022-2033 (Revenue USD Bn)
12.2. U.S. Global Point-of-care Molecular Diagnostics Market
12.2.1. U.S. Point-of-care Molecular Diagnostics Market Size and Forecast, 2022-2033 (Revenue USD Bn)
12.2.2. U.S. Point-of-care Molecular Diagnostics Market Size and Forecast, By Technology, 2022-2033 (Revenue USD Bn)
12.2.3. U.S. Point-of-care Molecular Diagnostics Market Size and Forecast, By Application, 2022-2033 (Revenue USD Bn)
12.2.4. U.S. Point-of-care Molecular Diagnostics Market Size and Forecast, By Test Location, 2022-2033 (Revenue USD Bn)
12.2.5. U.S. Point-of-care Molecular Diagnostics Market Size and Forecast, By End-user, 2022-2033 (Revenue USD Bn)
12.3. Canada Global Point-of-care Molecular Diagnostics Market
12.3.1. Canada Point-of-care Molecular Diagnostics Market Size and Forecast, 2022-2033 (Revenue USD Bn)
12.3.2. Canada Point-of-care Molecular Diagnostics Market Size and Forecast, By Technology, 2022-2033 (Revenue USD Bn)
12.3.3. Canada Point-of-care Molecular Diagnostics Market Size and Forecast, By Application, 2022-2033 (Revenue USD Bn)
12.3.4. Canada Point-of-care Molecular Diagnostics Market Size and Forecast, By Test Location, 2022-2033 (Revenue USD Bn)
12.3.5. Canada Point-of-care Molecular Diagnostics Market Size and Forecast, By End-user, 2022-2033 (Revenue USD Bn)
13. Europe Global Point-of-care Molecular Diagnostics Market
13.1. Europe Global Point-of-care Molecular Diagnostics Market
13.1.1. Europe Point-of-care Molecular Diagnostics Market Size and Forecast, 2022-2033 (Revenue USD Bn)
13.1.2. Europe Point-of-care Molecular Diagnostics Market Size and Forecast, By Country, 2022-2033 (Revenue USD Bn)
13.1.3. Europe Point-of-care Molecular Diagnostics Market Size and Forecast, By Technology, 2022-2033 (Revenue USD Bn)
13.1.4. Europe Point-of-care Molecular Diagnostics Market Size and Forecast, By Application, 2022-2033 (Revenue USD Bn)
13.1.5. Europe Point-of-care Molecular Diagnostics Market Size and Forecast, By Test Location, 2022-2033 (Revenue USD Bn)
13.1.6. Europe Point-of-care Molecular Diagnostics Market Size and Forecast, By End-user, 2022-2033 (Revenue USD Bn)
13.2. Germany Global Point-of-care Molecular Diagnostics Market
13.2.1. Germany Point-of-care Molecular Diagnostics Market Size and Forecast, 2022-2033 (Revenue USD Bn)
13.2.2. Germany Point-of-care Molecular Diagnostics Market Size and Forecast, By Technology, 2022-2033 (Revenue USD Bn)
13.2.3. Germany Point-of-care Molecular Diagnostics Market Size and Forecast, By Application, 2022-2033 (Revenue USD Bn)
13.2.4. Germany Point-of-care Molecular Diagnostics Market Size and Forecast, By Test Location, 2022-2033 (Revenue USD Bn)
13.2.5. Germany Point-of-care Molecular Diagnostics Market Size and Forecast, By End-user, 2022-2033 (Revenue USD Bn)
13.3. UK Global Point-of-care Molecular Diagnostics Market
13.3.1. UK Point-of-care Molecular Diagnostics Market Size and Forecast, 2022-2033 (Revenue USD Bn)
13.3.2. UK Point-of-care Molecular Diagnostics Market Size and Forecast, By Technology, 2022-2033 (Revenue USD Bn)
13.3.3. UK Point-of-care Molecular Diagnostics Market Size and Forecast, By Application, 2022-2033 (Revenue USD Bn)
13.3.4. UK Point-of-care Molecular Diagnostics Market Size and Forecast, By Test Location, 2022-2033 (Revenue USD Bn)
13.3.5. UK Point-of-care Molecular Diagnostics Market Size and Forecast, By End-user, 2022-2033 (Revenue USD Bn)
13.4. France Global Point-of-care Molecular Diagnostics Market
13.4.1. France Point-of-care Molecular Diagnostics Market Size and Forecast, 2022-2033 (Revenue USD Bn)
13.4.2. France Point-of-care Molecular Diagnostics Market Size and Forecast, By Technology, 2022-2033 (Revenue USD Bn)
13.4.3. France Point-of-care Molecular Diagnostics Market Size and Forecast, By Application, 2022-2033 (Revenue USD Bn)
13.4.4. France Point-of-care Molecular Diagnostics Market Size and Forecast, By Test Location, 2022-2033 (Revenue USD Bn)
13.4.5. France Point-of-care Molecular Diagnostics Market Size and Forecast, By End-user, 2022-2033 (Revenue USD Bn)
13.5. Spain Global Point-of-care Molecular Diagnostics Market
13.5.1. Spain Point-of-care Molecular Diagnostics Market Size and Forecast, 2022-2033 (Revenue USD Bn)
13.5.2. Spain Point-of-care Molecular Diagnostics Market Size and Forecast, By Technology, 2022-2033 (Revenue USD Bn)
13.5.3. Spain Point-of-care Molecular Diagnostics Market Size and Forecast, By Application, 2022-2033 (Revenue USD Bn)
13.5.4. Spain Point-of-care Molecular Diagnostics Market Size and Forecast, By Test Location, 2022-2033 (Revenue USD Bn)
13.5.5. Spain Point-of-care Molecular Diagnostics Market Size and Forecast, By End-user, 2022-2033 (Revenue USD Bn)
13.6. Italy Global Point-of-care Molecular Diagnostics Market
13.6.1. Italy Point-of-care Molecular Diagnostics Market Size and Forecast, 2022-2033 (Revenue USD Bn)
13.6.2. Italy Point-of-care Molecular Diagnostics Market Size and Forecast, By Technology, 2022-2033 (Revenue USD Bn)
13.6.3. Italy Point-of-care Molecular Diagnostics Market Size and Forecast, By Application, 2022-2033 (Revenue USD Bn)
13.6.4. Italy Point-of-care Molecular Diagnostics Market Size and Forecast, By Test Location, 2022-2033 (Revenue USD Bn)
13.6.5. Italy Point-of-care Molecular Diagnostics Market Size and Forecast, By End-user, 2022-2033 (Revenue USD Bn)
13.7. Rest of Europe Global Point-of-care Molecular Diagnostics Market
13.7.1. Rest of Europe Point-of-care Molecular Diagnostics Market Size and Forecast, 2022-2033 (Revenue USD Bn)
13.7.2. Rest of Europe Point-of-care Molecular Diagnostics Market Size and Forecast, By Technology, 2022-2033 (Revenue USD Bn)
13.7.3. Rest of Europe Point-of-care Molecular Diagnostics Market Size and Forecast, By Application, 2022-2033 (Revenue USD Bn)
13.7.4. Rest of Europe Point-of-care Molecular Diagnostics Market Size and Forecast, By Test Location, 2022-2033 (Revenue USD Bn)
13.7.5. Rest of Europe Point-of-care Molecular Diagnostics Market Size and Forecast, By End-user, 2022-2033 (Revenue USD Bn)
14. Asia Pacific Global Point-of-care Molecular Diagnostics Market
14.1. Asia Pacific Global Point-of-care Molecular Diagnostics Market
14.1.1. Asia Pacific Point-of-care Molecular Diagnostics Market Size and Forecast, 2022-2033 (Revenue USD Bn)
14.1.2. Asia Pacific Point-of-care Molecular Diagnostics Market Size and Forecast, By Country, 2022-2033 (Revenue USD Bn)
14.1.3. Asia Pacific Point-of-care Molecular Diagnostics Market Size and Forecast, By Technology, 2022-2033 (Revenue USD Bn)
14.1.4. Asia Pacific Point-of-care Molecular Diagnostics Market Size and Forecast, By Application, 2022-2033 (Revenue USD Bn)
14.1.5. Asia Pacific Point-of-care Molecular Diagnostics Market Size and Forecast, By Test Location, 2022-2033 (Revenue USD Bn)
14.1.6. Asia Pacific Point-of-care Molecular Diagnostics Market Size and Forecast, By End-user, 2022-2033 (Revenue USD Bn)
14.2. Japan Global Point-of-care Molecular Diagnostics Market
14.2.1. Japan Point-of-care Molecular Diagnostics Market Size and Forecast, 2022-2033 (Revenue USD Bn)
14.2.2. Japan Point-of-care Molecular Diagnostics Market Size and Forecast, By Technology, 2022-2033 (Revenue USD Bn)
14.2.3. Japan Point-of-care Molecular Diagnostics Market Size and Forecast, By Application, 2022-2033 (Revenue USD Bn)
14.2.4. Japan Point-of-care Molecular Diagnostics Market Size and Forecast, By Test Location, 2022-2033 (Revenue USD Bn)
14.2.5. Japan Point-of-care Molecular Diagnostics Market Size and Forecast, By End-user, 2022-2033 (Revenue USD Bn)
14.3. China Global Point-of-care Molecular Diagnostics Market
14.3.1. China Point-of-care Molecular Diagnostics Market Size and Forecast, 2022-2033 (Revenue USD Bn)
14.3.2. China Point-of-care Molecular Diagnostics Market Size and Forecast, By Technology, 2022-2033 (Revenue USD Bn)
14.3.3. China Point-of-care Molecular Diagnostics Market Size and Forecast, By Application, 2022-2033 (Revenue USD Bn)
14.3.4. China Point-of-care Molecular Diagnostics Market Size and Forecast, By Test Location, 2022-2033 (Revenue USD Bn)
14.3.5. China Point-of-care Molecular Diagnostics Market Size and Forecast, By End-user, 2022-2033 (Revenue USD Bn)
14.4. India Global Point-of-care Molecular Diagnostics Market
14.4.1. India Point-of-care Molecular Diagnostics Market Size and Forecast, 2022-2033 (Revenue USD Bn)
14.4.2. India Point-of-care Molecular Diagnostics Market Size and Forecast, By Technology, 2022-2033 (Revenue USD Bn)
14.4.3. India Point-of-care Molecular Diagnostics Market Size and Forecast, By Application, 2022-2033 (Revenue USD Bn)
14.4.4. India Point-of-care Molecular Diagnostics Market Size and Forecast, By Test Location, 2022-2033 (Revenue USD Bn)
14.4.5. India Point-of-care Molecular Diagnostics Market Size and Forecast, By End-user, 2022-2033 (Revenue USD Bn)
14.5. South Korea Global Point-of-care Molecular Diagnostics Market
14.5.1. South Korea Point-of-care Molecular Diagnostics Market Size and Forecast, 2022-2033 (Revenue USD Bn)
14.5.2. South Korea Point-of-care Molecular Diagnostics Market Size and Forecast, By Technology, 2022-2033 (Revenue USD Bn)
14.5.3. South Korea Point-of-care Molecular Diagnostics Market Size and Forecast, By Application, 2022-2033 (Revenue USD Bn)
14.5.4. South Korea Point-of-care Molecular Diagnostics Market Size and Forecast, By Test Location, 2022-2033 (Revenue USD Bn)
14.5.5. South Korea Point-of-care Molecular Diagnostics Market Size and Forecast, By End-user, 2022-2033 (Revenue USD Bn)
14.6. Australia Global Point-of-care Molecular Diagnostics Market
14.6.1. Australia Point-of-care Molecular Diagnostics Market Size and Forecast, 2022-2033 (Revenue USD Bn)
14.6.2. Australia Point-of-care Molecular Diagnostics Market Size and Forecast, By Technology, 2022-2033 (Revenue USD Bn)
14.6.3. Australia Point-of-care Molecular Diagnostics Market Size and Forecast, By Application, 2022-2033 (Revenue USD Bn)
14.6.4. Australia Point-of-care Molecular Diagnostics Market Size and Forecast, By Test Location, 2022-2033 (Revenue USD Bn)
14.6.5. Australia Point-of-care Molecular Diagnostics Market Size and Forecast, By End-user, 2022-2033 (Revenue USD Bn)
14.7. Rest of Asia Pacific Global Point-of-care Molecular Diagnostics Market
14.7.1. Rest of Asia Pacific Point-of-care Molecular Diagnostics Market Size and Forecast, 2022-2033 (Revenue USD Bn)
14.7.2. Rest of Asia Pacific Point-of-care Molecular Diagnostics Market Size and Forecast, By Technology, 2022-2033 (Revenue USD Bn)
14.7.3. Rest of Asia Pacific Point-of-care Molecular Diagnostics Market Size and Forecast, By Application, 2022-2033 (Revenue USD Bn)
14.7.4. Rest of Asia Pacific Point-of-care Molecular Diagnostics Market Size and Forecast, By Test Location, 2022-2033 (Revenue USD Bn)
14.7.5. Rest of Asia Pacific Point-of-care Molecular Diagnostics Market Size and Forecast, By End-user, 2022-2033 (Revenue USD Bn)
15. Latin America Global Point-of-care Molecular Diagnostics Market
15.1. Latin America Global Point-of-care Molecular Diagnostics Market
15.1.1. Latin America Point-of-care Molecular Diagnostics Market Size and Forecast, 2022-2033 (Revenue USD Bn)
15.1.2. Latin America Point-of-care Molecular Diagnostics Market Size and Forecast, By Country, 2022-2033 (Revenue USD Bn)
15.1.3. Latin America Point-of-care Molecular Diagnostics Market Size and Forecast, By Technology, 2022-2033 (Revenue USD Bn)
15.1.4. Latin America Point-of-care Molecular Diagnostics Market Size and Forecast, By Application, 2022-2033 (Revenue USD Bn)
15.1.5. Latin America Point-of-care Molecular Diagnostics Market Size and Forecast, By Test Location, 2022-2033 (Revenue USD Bn)
15.1.6. Latin America Point-of-care Molecular Diagnostics Market Size and Forecast, By End-user, 2022-2033 (Revenue USD Bn)
15.2. Brazil Global Point-of-care Molecular Diagnostics Market
15.2.1. Brazil Point-of-care Molecular Diagnostics Market Size and Forecast, 2022-2033 (Revenue USD Bn)
15.2.2. Brazil Point-of-care Molecular Diagnostics Market Size and Forecast, By Technology, 2022-2033 (Revenue USD Bn)
15.2.3. Brazil Point-of-care Molecular Diagnostics Market Size and Forecast, By Application, 2022-2033 (Revenue USD Bn)
15.2.4. Brazil Point-of-care Molecular Diagnostics Market Size and Forecast, By Test Location, 2022-2033 (Revenue USD Bn)
15.2.5. Brazil Point-of-care Molecular Diagnostics Market Size and Forecast, By End-user, 2022-2033 (Revenue USD Bn)
15.3. Mexico Global Point-of-care Molecular Diagnostics Market
15.3.1. Mexico Point-of-care Molecular Diagnostics Market Size and Forecast, 2022-2033 (Revenue USD Bn)
15.3.2. Mexico Point-of-care Molecular Diagnostics Market Size and Forecast, By Technology, 2022-2033 (Revenue USD Bn)
15.3.3. Mexico Point-of-care Molecular Diagnostics Market Size and Forecast, By Application, 2022-2033 (Revenue USD Bn)
15.3.4. Mexico Point-of-care Molecular Diagnostics Market Size and Forecast, By Test Location, 2022-2033 (Revenue USD Bn)
15.3.5. Mexico Point-of-care Molecular Diagnostics Market Size and Forecast, By End-user, 2022-2033 (Revenue USD Bn)
15.4. Argentina Global Point-of-care Molecular Diagnostics Market
15.4.1. Argentina Point-of-care Molecular Diagnostics Market Size and Forecast, 2022-2033 (Revenue USD Bn)
15.4.2. Argentina Point-of-care Molecular Diagnostics Market Size and Forecast, By Technology, 2022-2033 (Revenue USD Bn)
15.4.3. Argentina Point-of-care Molecular Diagnostics Market Size and Forecast, By Application, 2022-2033 (Revenue USD Bn)
15.4.4. Argentina Point-of-care Molecular Diagnostics Market Size and Forecast, By Test Location, 2022-2033 (Revenue USD Bn)
15.4.5. Argentina Point-of-care Molecular Diagnostics Market Size and Forecast, By End-user, 2022-2033 (Revenue USD Bn)
15.5. Rest of Latin America Global Point-of-care Molecular Diagnostics Market
15.5.1. Rest of Latin America Point-of-care Molecular Diagnostics Market Size and Forecast, 2022-2033 (Revenue USD Bn)
15.5.2. Rest of Latin America Point-of-care Molecular Diagnostics Market Size and Forecast, By Technology, 2022-2033 (Revenue USD Bn)
15.5.3. Rest of Latin America Point-of-care Molecular Diagnostics Market Size and Forecast, By Application, 2022-2033 (Revenue USD Bn)
15.5.4. Rest of Latin America Point-of-care Molecular Diagnostics Market Size and Forecast, By Test Location, 2022-2033 (Revenue USD Bn)
15.5.5. Rest of Latin America Point-of-care Molecular Diagnostics Market Size and Forecast, By End-user, 2022-2033 (Revenue USD Bn)
16. MEA Global Point-of-care Molecular Diagnostics Market
16.1. MEA Global Point-of-care Molecular Diagnostics Market
16.1.1. MEA Point-of-care Molecular Diagnostics Market Size and Forecast, 2022-2033 (Revenue USD Bn)
16.1.2. MEA Point-of-care Molecular Diagnostics Market Size and Forecast, By Country, 2022-2033 (Revenue USD Bn)
16.1.3. MEA Point-of-care Molecular Diagnostics Market Size and Forecast, By Technology, 2022-2033 (Revenue USD Bn)
16.1.4. MEA Point-of-care Molecular Diagnostics Market Size and Forecast, By Application, 2022-2033 (Revenue USD Bn)
16.1.5. MEA Point-of-care Molecular Diagnostics Market Size and Forecast, By Test Location, 2022-2033 (Revenue USD Bn)
16.1.6. MEA Point-of-care Molecular Diagnostics Market Size and Forecast, By End-user, 2022-2033 (Revenue USD Bn)
16.2. GCC Global Point-of-care Molecular Diagnostics Market
16.2.1. GCC Point-of-care Molecular Diagnostics Market Size and Forecast, 2022-2033 (Revenue USD Bn)
16.2.2. GCC Point-of-care Molecular Diagnostics Market Size and Forecast, By Technology, 2022-2033 (Revenue USD Bn)
16.2.3. GCC Point-of-care Molecular Diagnostics Market Size and Forecast, By Application, 2022-2033 (Revenue USD Bn)
16.2.4. GCC Point-of-care Molecular Diagnostics Market Size and Forecast, By Test Location, 2022-2033 (Revenue USD Bn)
16.2.5. GCC Point-of-care Molecular Diagnostics Market Size and Forecast, By End-user, 2022-2033 (Revenue USD Bn)
16.3. South Africa Global Point-of-care Molecular Diagnostics Market
16.3.1. South Africa Point-of-care Molecular Diagnostics Market Size and Forecast, 2022-2033 (Revenue USD Bn)
16.3.2. South Africa Point-of-care Molecular Diagnostics Market Size and Forecast, By Technology, 2022-2033 (Revenue USD Bn)
16.3.3. South Africa Point-of-care Molecular Diagnostics Market Size and Forecast, By Application, 2022-2033 (Revenue USD Bn)
16.3.4. South Africa Point-of-care Molecular Diagnostics Market Size and Forecast, By Test Location, 2022-2033 (Revenue USD Bn)
16.3.5. South Africa Point-of-care Molecular Diagnostics Market Size and Forecast, By End-user, 2022-2033 (Revenue USD Bn)
16.4. Rest of MEA Global Point-of-care Molecular Diagnostics Market
16.4.1. Rest of MEA Point-of-care Molecular Diagnostics Market Size and Forecast, 2022-2033 (Revenue USD Bn)
16.4.2. Rest of MEA Point-of-care Molecular Diagnostics Market Size and Forecast, By Technology, 2022-2033 (Revenue USD Bn)
16.4.3. Rest of MEA Point-of-care Molecular Diagnostics Market Size and Forecast, By Application, 2022-2033 (Revenue USD Bn)
16.4.4. Rest of MEA Point-of-care Molecular Diagnostics Market Size and Forecast, By Test Location, 2022-2033 (Revenue USD Bn)
16.4.5. Rest of MEA Point-of-care Molecular Diagnostics Market Size and Forecast, By End-user, 2022-2033 (Revenue USD Bn)
17. Competitor Analysis
17.1. Company Market Share Analysis, 2022
17.2. Major Recent Developments
18. Company Profiles
18.1. Bayer AG
18.2. Abott
18.3. QIAGEN
18.4. Abaxis
18.5. Danaher
18.6. Agilent Technologies
18.7. OraSure Technologies
18.8. Other Prominent Players
19. Conclusion20. Recommendations

Companies Mentioned

  • Bayer AG
  • Abbott
  • QIAGEN
  • Abaxis
  • Danaher
  • Agilent Technologies
  • OraSure Technologies

Table Information